NO985539L - Farmas÷ytiske blandinger - Google Patents

Farmas÷ytiske blandinger

Info

Publication number
NO985539L
NO985539L NO985539A NO985539A NO985539L NO 985539 L NO985539 L NO 985539L NO 985539 A NO985539 A NO 985539A NO 985539 A NO985539 A NO 985539A NO 985539 L NO985539 L NO 985539L
Authority
NO
Norway
Prior art keywords
pharmaceutical
surface mixtures
mixtures
Prior art date
Application number
NO985539A
Other languages
English (en)
Other versions
NO327801B1 (no
NO985539D0 (no
Inventor
Bhavnish Vinod Parikh
Robert Joseph Timko
William Joseph Addicks
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10794541&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO985539(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of NO985539L publication Critical patent/NO985539L/no
Publication of NO985539D0 publication Critical patent/NO985539D0/no
Publication of NO327801B1 publication Critical patent/NO327801B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO19985539A 1996-05-31 1998-11-27 Formulering med retardert frigivning, anvendelse derav og fremgangsmate for fremstilling av formuleringen. NO327801B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9611328.7A GB9611328D0 (en) 1996-05-31 1996-05-31 Pharmaceutical compositions
PCT/GB1997/001432 WO1997045124A1 (en) 1996-05-31 1997-05-27 Pharmaceutical compositions

Publications (3)

Publication Number Publication Date
NO985539L true NO985539L (no) 1998-11-27
NO985539D0 NO985539D0 (no) 1998-11-27
NO327801B1 NO327801B1 (no) 2009-09-28

Family

ID=10794541

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19985539A NO327801B1 (no) 1996-05-31 1998-11-27 Formulering med retardert frigivning, anvendelse derav og fremgangsmate for fremstilling av formuleringen.

Country Status (31)

Country Link
EP (1) EP0907364B1 (no)
JP (5) JP2000511170A (no)
CN (3) CN101006985A (no)
AR (1) AR003662A1 (no)
AT (1) ATE222105T1 (no)
AU (1) AU727219B2 (no)
BR (1) BR9709271A (no)
CA (1) CA2251944C (no)
CZ (1) CZ293760B6 (no)
DE (1) DE69714739T2 (no)
DK (1) DK0907364T3 (no)
EG (1) EG24118A (no)
ES (1) ES2182079T3 (no)
GB (2) GB9611328D0 (no)
HR (1) HRP970299B1 (no)
HU (1) HU225152B1 (no)
ID (1) ID18352A (no)
IL (1) IL127222A (no)
MY (1) MY120120A (no)
NO (1) NO327801B1 (no)
NZ (1) NZ332198A (no)
PL (1) PL189887B1 (no)
PT (1) PT907364E (no)
RU (1) RU2201754C2 (no)
SI (1) SI0907364T1 (no)
SK (1) SK284131B6 (no)
TR (1) TR199802483T2 (no)
TW (1) TW550076B (no)
UA (1) UA50772C2 (no)
WO (1) WO1997045124A1 (no)
ZA (1) ZA974735B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9922271D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Formulation
SE0003126D0 (sv) 2000-09-05 2000-09-05 Astrazeneca Ab Method of treatment
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
SE0102855D0 (sv) * 2001-08-27 2001-08-27 Astrazeneca Ab Method of treatment
WO2003039516A1 (en) * 2001-11-07 2003-05-15 Fujisawa Pharmaceuticla Co., Ltd. Method for improving dissolution of poorly dispersible medicaments
TW200735878A (en) * 2005-11-18 2007-10-01 Astrazeneca Ab Pharmaceutical compositions
EP1976487A2 (en) 2006-01-25 2008-10-08 Astron Research Limited Sustained release dosage form of phenothiazine derivatives containing channelizer
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
GB0618879D0 (en) 2006-09-26 2006-11-01 Zysis Ltd Pharmaceutical compositions
DE602007009036D1 (de) 2007-02-14 2010-10-21 Lesvi Laboratorios Sl Pharmazeutische Zusammensetzungen mit Quetiapinfumarat
WO2008110337A2 (en) 2007-03-09 2008-09-18 Synthon B.V. Pharmaceutical composition of quetiapine fumarate
US20080287418A1 (en) * 2007-05-16 2008-11-20 Astrazeneca Ab Extended Release Compositions and Methods for Their Manufacture
DK2262486T3 (da) 2008-08-01 2013-03-25 Krka Tovarna Zdravil D D Novo Mesto Quetiapin sammensætning
EP2153834A3 (en) 2008-08-07 2010-02-24 Farmaprojects, S.A. Extended release pharmaceutical compositions comprising quetiapine salts
DE102008046650A1 (de) * 2008-09-10 2010-03-11 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Quetiapin enthaltende Retardtablette
WO2010082220A2 (en) * 2009-01-05 2010-07-22 Torrent Pharmaceuticals Limited Sustained release pharmaceutical composition of quetiapine and process for preparation thereof
WO2010089259A2 (en) 2009-02-04 2010-08-12 Woerwag R&D Gmbh Sustained release composition containing quetiapine
EP2233130A1 (en) * 2009-03-23 2010-09-29 Genepharm (Europe) Trading Limited A sustained release oral composition of an antipsychotic agent
TWI478733B (zh) * 2009-05-13 2015-04-01 Wyeth Llc 突釋藥物釋放組合物
WO2011132008A2 (en) 2010-04-22 2011-10-27 EGIS Gyűgyszergyár Nyilvánosan Múködő Részvény társaság Controlled release pharmaceutical composition
WO2011154118A1 (en) 2010-06-07 2011-12-15 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Quetiapine prolonged-release tablets
DE102010033527A1 (de) 2010-08-05 2012-02-09 Acino Pharma Ag Quetiapin-Tabletten
TR201008261A1 (tr) 2010-10-08 2012-04-24 Sanovel İlaç San. Ve Ti̇c. A.Ş. Kontrollü salım gerçekleştiren ketiapin formülasyonları
CN102218042A (zh) * 2011-05-26 2011-10-19 青岛黄海制药有限责任公司 富马酸喹硫平组合物的缓释片剂及其制备方法
DE102011115690A1 (de) 2011-10-11 2013-04-11 Acino Pharma Ag Quetiapin enthaltende Formulierungen
CN102406606B (zh) * 2011-11-29 2013-01-23 海南美大制药有限公司 富马酸喹硫平脂质体固体制剂
WO2014037022A1 (en) 2012-09-10 2014-03-13 Pharmathen S.A. Pharmaceutical composition comprising an atypical antipsychotic agent and method for the preparation thereof
EP2848244A1 (en) 2013-09-16 2015-03-18 Yildiz Özsoy Erginer Extended release tablet formulations of quetiapine
WO2016204939A1 (en) * 2015-06-19 2016-12-22 Biotie Therapies, Inc. Controlled-release tozadenant formulations
CN106187873B (zh) * 2016-07-25 2019-11-05 宜春学院 一种芳胺基烷基氧类化合物及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
US4775535A (en) * 1986-04-04 1988-10-04 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
EP0266707B1 (en) * 1986-11-03 1992-01-22 Schering Corporation Sustained release labetalol tablet
IE59540B1 (en) * 1987-01-09 1994-03-09 Elan Corp Sustained release capsule or tablet formulation
GB8705574D0 (en) * 1987-03-10 1987-04-15 Ici Plc Preparation of thiazepine compound
US4983398A (en) * 1987-12-21 1991-01-08 Forest Laboratories, Inc. Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
SE9003902D0 (sv) * 1990-12-07 1990-12-07 Astra Ab Solid dosage forms of a drug
IT1256651B (it) * 1992-12-11 1995-12-12 Giancarlo Santus Composizione farmaceutica a rilascio controllato in sospensione liquida
JP3116970B2 (ja) * 1991-06-12 2000-12-11 三菱東京製薬株式会社 ペミロラストカリウムの徐放性製剤
IT1256393B (it) * 1992-11-17 1995-12-04 Inverni Della Beffa Spa Forme matriciali multistrato per il rilascio controllato di principi attivi
US5393765A (en) * 1993-12-13 1995-02-28 Hoffmann-La Roche Inc. Pharmaceutical compositions with constant erosion volume for zero order controlled release
WO1995031186A1 (en) * 1994-05-13 1995-11-23 Smithkline Beecham Corporation Method and composition for increasing calcium uptake

Also Published As

Publication number Publication date
CN1219879A (zh) 1999-06-16
TW550076B (en) 2003-09-01
HRP970299B1 (en) 2001-12-31
PT907364E (pt) 2002-12-31
NZ332198A (en) 2000-05-26
NO327801B1 (no) 2009-09-28
BR9709271A (pt) 1999-08-10
HUP9902194A2 (hu) 2000-02-28
SI0907364T1 (en) 2003-02-28
DE69714739D1 (de) 2002-09-19
UA50772C2 (uk) 2002-11-15
MY120120A (en) 2005-09-30
AU2967597A (en) 1998-01-05
GB9611328D0 (en) 1996-08-07
AU727219B2 (en) 2000-12-07
JP2007119495A (ja) 2007-05-17
AR003662A1 (es) 1998-09-09
JP2012031206A (ja) 2012-02-16
SK284131B6 (sk) 2004-09-08
CN101006985A (zh) 2007-08-01
ID18352A (id) 1998-04-02
PL330223A1 (en) 1999-05-10
TR199802483T2 (xx) 1999-02-22
RU2201754C2 (ru) 2003-04-10
CZ388098A3 (cs) 1999-02-17
GB9709761D0 (en) 1997-07-09
CN1142780C (zh) 2004-03-24
EG24118A (en) 2008-07-06
SK163998A3 (en) 1999-05-07
ATE222105T1 (de) 2002-08-15
CZ293760B6 (cs) 2004-07-14
DK0907364T3 (da) 2002-11-11
HRP970299A2 (en) 1998-04-30
JP2014167026A (ja) 2014-09-11
WO1997045124A1 (en) 1997-12-04
HUP9902194A3 (en) 2000-03-28
ES2182079T3 (es) 2003-03-01
JP2000511170A (ja) 2000-08-29
DE69714739T2 (de) 2003-05-15
EP0907364A1 (en) 1999-04-14
HU225152B1 (en) 2006-07-28
JP5888549B2 (ja) 2016-03-22
NO985539D0 (no) 1998-11-27
JP2006152006A (ja) 2006-06-15
IL127222A (en) 2001-03-19
CA2251944C (en) 2007-04-10
PL189887B1 (pl) 2005-10-31
ZA974735B (en) 1997-12-01
CA2251944A1 (en) 1997-12-04
EP0907364B1 (en) 2002-08-14
IL127222A0 (en) 2000-06-01
CN1511532A (zh) 2004-07-14

Similar Documents

Publication Publication Date Title
NO985539L (no) Farmas÷ytiske blandinger
NO964600L (no) Slagverkt÷y
NO982302D0 (no) Farmas÷ytisk sammensetning
NO985337D0 (no) Tetrahydrolipstatin-holdige blandinger
NO975495L (no) Br÷nnhodeenhet
NO975032L (no) R÷rskj÷t
ID24176A (id) Bahan pembantu sementasi
DK0783302T3 (da) Lægemidler
DE69729078D1 (de) Heterogene schaumstoffmaterialien
IS1988B (is) Interferon tengd efni
NO20001776D0 (no) Medikamenter
PT938496E (pt) Misturas insecticidas sinergicas
DE69719823D1 (de) Blisterverpackung
DE69834448D1 (de) Kontaktwerkstoffe
NO303333B1 (no) H÷yhastighetsror
NO985466L (no) Integrert stubbr÷r
IS5445A (is) Statín-karboxýalkýleter-blöndur
NO994619L (no) Farmasöytiske blandinger
NO990801D0 (no) Blekeblandinger
NO304660L (no) L÷fteanordning
DE69702724D1 (de) Vibrator
NO20003141D0 (no) Farmasøytiske blandinger
NO961589D0 (no) Farmasöytiske blandinger
NO990645D0 (no) Blekeblandinger
NO982318D0 (no) Br÷nnfluid

Legal Events

Date Code Title Description
MK1K Patent expired